IN2015DN02685A - - Google Patents

Download PDF

Info

Publication number
IN2015DN02685A
IN2015DN02685A IN2685DEN2015A IN2015DN02685A IN 2015DN02685 A IN2015DN02685 A IN 2015DN02685A IN 2685DEN2015 A IN2685DEN2015 A IN 2685DEN2015A IN 2015DN02685 A IN2015DN02685 A IN 2015DN02685A
Authority
IN
India
Prior art keywords
subject
cancer
radiation
predisposition
copd
Prior art date
Application number
Other languages
English (en)
Inventor
Diana; Anderson
Mojgan; Jafzadeh
Morgan Clive Thomas; Denyer
Original Assignee
Univ Bradford
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Bradford filed Critical Univ Bradford
Publication of IN2015DN02685A publication Critical patent/IN2015DN02685A/en

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483Physical analysis of biological material
    • G01N33/487Physical analysis of biological material of liquid biological material
    • G01N33/49Blood
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/50Determining the risk of developing a disease
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/70Mechanisms involved in disease identification
    • G01N2800/7004Stress
    • G01N2800/7009Oxidative stress
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/70Mechanisms involved in disease identification
    • G01N2800/7023(Hyper)proliferation
    • G01N2800/7028Cancer

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Ecology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
IN2685DEN2015 2012-09-11 2013-09-10 IN2015DN02685A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1216174.1A GB201216174D0 (en) 2012-09-11 2012-09-11 Method of determining a predisposition to disease states characterised by free redical induced dna damage
PCT/GB2013/052365 WO2014041340A1 (fr) 2012-09-11 2013-09-10 Procédés et produits de dosages pour déterminer la prédisposition d'un sujet à des pathologies caractérisées par un dommage à l'adn induit par des radicaux libres

Publications (1)

Publication Number Publication Date
IN2015DN02685A true IN2015DN02685A (fr) 2015-09-04

Family

ID=47137246

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2685DEN2015 IN2015DN02685A (fr) 2012-09-11 2013-09-10

Country Status (7)

Country Link
US (1) US20150219619A1 (fr)
EP (1) EP2895853A1 (fr)
JP (1) JP2015529077A (fr)
CN (1) CN104755927A (fr)
GB (1) GB201216174D0 (fr)
IN (1) IN2015DN02685A (fr)
WO (1) WO2014041340A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9931634B2 (en) 2014-02-27 2018-04-03 The Regents Of The Univeristy Of California High throughput DNA damage quantification of human tissue with home-based collection device
JP2023546212A (ja) 2020-10-22 2023-11-01 フォーディー ライフテック アーゲー がん及びがん易罹患性の検出のための新規なバイオマーカーとしてのdna損傷感受性

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007103116A2 (fr) * 2006-03-02 2007-09-13 Laboratory Corporation Of America Holdings Procédés et systèmes pour évaluer les facteurs de risques de santé par mesurage des dommages à l'adn et de sa réparation

Also Published As

Publication number Publication date
US20150219619A1 (en) 2015-08-06
JP2015529077A (ja) 2015-10-05
GB201216174D0 (en) 2012-10-24
EP2895853A1 (fr) 2015-07-22
CN104755927A (zh) 2015-07-01
WO2014041340A1 (fr) 2014-03-20

Similar Documents

Publication Publication Date Title
ZA201903597B (en) Biosensors for biological or chemical analysis and methods of manufacturing the same
WO2015094995A3 (fr) Biomarqueurs de signature génique de réponse tumorale à des antagonistes de pd-1
WO2014144657A3 (fr) Compositions et procédés pour le pronostic de cancer
WO2014028378A3 (fr) Procédés et systèmes de détection de composants biologiques
EP3236262A3 (fr) Essai de diagnostic fonctionnel de substitut pour le cancer
MX367366B (es) Composiciones y metodos para diagnosticar tumores de tiroides.
BR112014031365A2 (pt) métodos de detectar doenças ou condições
WO2012021887A3 (fr) Biomarqueurs pour la détection précoce du cancer du sein
CL2013003433A1 (es) Método para analizar una muestra biológica de un sujeto con cáncer que comprende determinar un nivel de expresión de los biomarcadores gli-1, otx-2, shroom2, pdlim3, y sphk1 en dicha muestra, en donde el nivel de expresión de los biomarcadores en coparación con un control, proporciona un indicador de diagnóstico de si el sujeto tiene una probabilidad aumentada de respuesta a: un ácido metil-4’-trifluorometoxi-bifenil-3-carboxílixo [6-(cis-2,6-dimetil-morfolino-4-il)-piridin-3-il]-amida, ó 2-[(r)-4-(6-bencil-4,5-dimetil-piridazin-3-il)-2-metil-3,4,5,6-tetrahidro-2h-[1,2’] bipirizanil-5’-il]-propan-2-ol; método para seleccionar a un sujeto que tiene cáncer para el tratamiento con uno de dichos compuestos, el cual comprende determinar el nivel de expresión de shroom2 o sphk1, en una muestra biológica del sujeto.
BR112014010955A2 (pt) sistema e método para processar amostras
EP4282405A3 (fr) Détection de biomarqueurs du cancer à l'aide de nanoparticules
GB2526736A (en) Methods, compositions, and kits for nucleic acid analysis
WO2013172779A3 (fr) Procédé pour indiquer la présence ou non-présence de cancer de la prostate
WO2013190075A3 (fr) Biomarqueurs spécifiques pour un carcinome hépatocellulaire (hcc)
MX358541B (es) Metodos para predecir el riesgo de desarrollar hipertension.
MX2014013079A (es) Metodo in vitro para el diagnostico y vigilancia del cancer.
MX357429B (es) Predictores para el tratamiento del cáncer.
MX2019010935A (es) Panel de marcadores geneticos para el diagnostico de cancer colorrectal.
EP2569635A4 (fr) Procédés de diagnostic et traitement de l'encéphalite ou de l'épilepsie
EP2738554A4 (fr) Nouveau procédé de traitement et d'analyse d'informations biologiques pour l'identification et la quantification de n-glycopeptides
WO2015095862A3 (fr) Biomarqueurs de micro-arn pour le cancer de l'ovaire
WO2015082416A8 (fr) Nouveaux biomarqueurs d'arn pour le diagnostic du cancer de la prostate
NZ716643A (en) Methods for predicting the risk of having a cardiovascular event and for monitoring the treatment of a cardiovascular event
EP2841926A4 (fr) Analyseur d'échantillons de tests biologiques
MX2016002529A (es) Marcadores de riesgo para cardiovasculopatias en pacientes con nefropatia cronica.